Yijing Capital
Shanghai, Shanghaiyijingcapital.com
Overview
Yijing Capital, founded in 2015, is a professional investment company with multiple investment platforms, undertaking equity investment with both self-owned and externally sourced funds . They primarily invest in industries with high growth potential, focusing on advanced technology, life sciences, and new forms of consumption & services sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Noah AI | Dec 2025 | Series A | Lead |
| TJ Biopharma | Sep 2025 | Series C Extension | Co-investor |
| Arnatar Therapeutics | Dec 2024 | Series A | Co-investor |
| VerTaxi | Sep 2024 | Early Funding | Co-investor |
| Arnatar Therapeutics | Apr 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
